SERZONE Drug Patent Profile
✉ Email this page to a colleague
When do Serzone patents expire, and what generic alternatives are available?
Serzone is a drug marketed by Bristol Myers Squibb and is included in one NDA.
The generic ingredient in SERZONE is nefazodone hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nefazodone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Serzone
A generic version of SERZONE was approved as nefazodone hydrochloride by TEVA on September 16th, 2003.
Summary for SERZONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 103 |
Clinical Trials: | 1 |
Patent Applications: | 1,195 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SERZONE at DailyMed |
Recent Clinical Trials for SERZONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Boston Medical Center | Phase 2 |
Boston University | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for SERZONE
US Patents and Regulatory Information for SERZONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb | SERZONE | nefazodone hydrochloride | TABLET;ORAL | 020152-001 | Dec 22, 1994 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | SERZONE | nefazodone hydrochloride | TABLET;ORAL | 020152-004 | Dec 22, 1994 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | SERZONE | nefazodone hydrochloride | TABLET;ORAL | 020152-002 | Dec 22, 1994 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SERZONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bristol Myers Squibb | SERZONE | nefazodone hydrochloride | TABLET;ORAL | 020152-003 | Dec 22, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Bristol Myers Squibb | SERZONE | nefazodone hydrochloride | TABLET;ORAL | 020152-002 | Dec 22, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Bristol Myers Squibb | SERZONE | nefazodone hydrochloride | TABLET;ORAL | 020152-001 | Dec 22, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SERZONE
See the table below for patents covering SERZONE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | H0524151 | ⤷ Try a Trial | |
Austria | A104582 | ⤷ Try a Trial | |
United Kingdom | 2142631 | 1,2,4-TRIAZOL-3-ONE ANTIDEPRESSANTS | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |